CLYM116’s Phase 1 Data Shows Favorable Safety Profile, Paving the Way for IgA Nephropathy Advancement
Market Chameleon (Mon, 8-Jun 11:46 AM)
Climb Bio Attracts $110 Million in Institutional Funding: What the Latest Private Placement Means for Investors
Market Chameleon (Tue, 28-Apr 7:35 AM)
